Temozolomide Capsule
Pricing Report NDC 47335-930-21

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Temozolomide (NDC 47335-930-21) is $313.40788 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 09, 2014.

As a a human prescription drug provided by Sun Pharmaceutical Industries, Inc., this medication is distributed in a 1 BOTTLE in 1 CARTON / 14 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$313.40788
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Apr 09, 2014
Data Status
As of Feb 11, 2015
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
47335-930-21
Description
1 BOTTLE in 1 CARTON / 14 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2014, the NADAC wholesale price for (NDC ) has moved within a range of $17.07360 to $313.40788 per EA. Over this 10 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$17.0736 - $313.4079
Market Volatility
1,735.63% Variance
Latest Trend
No Change
Date Unit Price Unit Source Method Rate
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Feb 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2025 $19.96666 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2025 $19.96666 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 18, 2024 $19.24340 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 18, 2024 $19.24340 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 20, 2024 $17.07360 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 20, 2024 $17.07360 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 09, 2014 $313.40788 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Apr 09, 2014 $313.40788 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 09, 2014 $313.40788 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Apr 09, 2014 $313.40788 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: June 17, 2026